Moleculin Biotech, Inc. Operating Expenses
Moleculin Biotech, Inc. (MBRX) reported Operating Expenses of $7.56 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-13
- Moleculin Biotech, Inc. operating expenses for the quarter ending 2026-06-30 was $7.56M, a 32.19% increase year-over-year.
- Moleculin Biotech, Inc. operating expenses for the quarter ending 2026-03-31 was $7.87M, a 32.49% increase year-over-year.
- Moleculin Biotech, Inc. operating expenses for the quarter ending 2025-12-31 was $7.53M, a 13.40% increase year-over-year.
- Moleculin Biotech, Inc. operating expenses for the quarter ending 2025-09-30 was $5.91M, a 17.22% decline year-over-year.
- Moleculin Biotech, Inc. operating expenses for fiscal 2025 was $25.10M, a 5.77% decline from fiscal 2024.
- Moleculin Biotech, Inc. operating expenses for fiscal 2024 was $26.64M, a 10.09% decline from fiscal 2023.
- Moleculin Biotech, Inc. operating expenses for fiscal 2023 was $29.63M, a 3.29% decline from fiscal 2022.
- Moleculin Biotech, Inc. operating expenses for fiscal 2022 was $30.64M, a 33.40% increase from fiscal 2021.
| Period end | Operating Expenses 2 month | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 5 month | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month | Operating Expenses 9 month as first filed | Operating Expenses 12 month | Operating Expenses 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $7.56M 10-Q · filed 2026-08-13 | $15.44M 10-Q · filed 2026-08-13 | $22.97M derived: sum of 3 quarters · filed 2026-08-13 | $28.87M derived: sum of 4 quarters · filed 2026-08-13 | ||||||
| 2026-03-31 | $7.87M 10-Q · filed 2026-05-14 | $15.41M derived: sum of 2 quarters · filed 2026-05-14 | $21.31M derived: sum of 3 quarters · filed 2026-05-14 | $27.03M derived: sum of 4 quarters · filed 2026-08-13 | ||||||
| 2025-12-31 | $7.53M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $13.44M derived: sum of 2 quarters · filed 2026-03-18 | $19.16M derived: sum of 3 quarters · filed 2026-08-13 | $25.10M 10-K · filed 2026-03-18 | ||||||
| 2025-09-30 | $5.91M 10-Q · filed 2025-11-13 | $11.63M derived: sum of 2 quarters · filed 2026-08-13 | $17.57M 10-Q · filed 2025-11-13 | $24.21M derived: sum of 4 quarters · filed 2026-08-13 | ||||||
| 2025-06-30 | $5.72M 10-Q · filed 2026-08-13 | $11.66M 10-Q · filed 2026-08-13 | $18.31M derived: sum of 3 quarters · filed 2026-08-13 | $25.44M derived: sum of 4 quarters · filed 2026-08-13 | ||||||
| 2025-03-31 | $5.94M 10-Q · filed 2026-05-14 | $12.59M derived: sum of 2 quarters · filed 2026-05-14 | $19.72M derived: sum of 3 quarters · filed 2026-05-14 | $25.91M derived: sum of 4 quarters · filed 2026-05-14 | ||||||
| 2024-12-31 | $6.64M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $13.78M derived: sum of 2 quarters · filed 2026-03-18 | $19.96M derived: sum of 3 quarters · filed 2026-03-18 | $26.64M 10-K · filed 2026-03-18 | ||||||
| 2024-09-30 | $7.13M 10-Q · filed 2025-11-13 | $13.32M derived: sum of 2 quarters · filed 2025-11-13 | $20.00M 10-Q · filed 2025-11-13 | $28.92M derived: sum of 4 quarters · filed 2025-11-13 | ||||||
| 2024-06-30 | $6.18M 10-Q · filed 2025-08-12 | $12.86M 10-Q · filed 2025-08-12 | $21.78M derived: sum of 3 quarters · filed 2025-08-12 | $27.73M derived: sum of 4 quarters · filed 2025-08-12 | ||||||
| 2024-03-31 | $6.68M 10-Q · filed 2025-05-13 | $15.60M derived: sum of 2 quarters · filed 2025-05-13 | $21.54M derived: sum of 3 quarters · filed 2025-05-13 | $27.95M derived: sum of 4 quarters · filed 2025-05-13 | ||||||
| 2023-12-31 | $8.92M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-21 | $14.87M derived: sum of 2 quarters · filed 2025-03-21 | $21.28M derived: sum of 3 quarters · filed 2025-03-21 | $29.63M 10-K · filed 2025-03-21 | ||||||
| 2023-09-30 | $5.95M 10-Q · filed 2024-11-08 | $12.36M derived: sum of 2 quarters · filed 2024-11-08 | $20.71M 10-Q · filed 2024-11-08 | $27.76M derived: sum of 4 quarters · filed 2024-11-08 | ||||||
| 2023-06-30 | $6.41M 10-Q · filed 2024-08-13 | $14.77M 10-Q · filed 2024-08-13 | $21.81M derived: sum of 3 quarters · filed 2024-08-13 | $30.90M derived: sum of 4 quarters · filed 2024-08-13 | ||||||
| 2023-03-31 | $8.35M 10-Q · filed 2024-05-10 | $15.40M derived: sum of 2 quarters · filed 2024-05-10 | $24.49M derived: sum of 3 quarters · filed 2024-05-10 | $31.92M derived: sum of 4 quarters · filed 2024-05-10 | ||||||
| 2022-12-31 | $7.05M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | $16.13M derived: sum of 2 quarters · filed 2024-03-22 | $23.57M derived: sum of 3 quarters · filed 2024-03-22 | $30.64M 10-K · filed 2024-03-22 | ||||||
| 2022-09-30 | $9.08M 10-Q · filed 2023-11-13 | $16.52M derived: sum of 2 quarters · filed 2023-11-13 | $23.59M 10-Q · filed 2023-11-13 | $28.80M derived: sum of 4 quarters · filed 2023-11-13 | ||||||
| 2022-06-30 | $7.43M 10-Q · filed 2023-08-10 | $14.51M 10-Q · filed 2023-08-10 | $19.71M derived: sum of 3 quarters · filed 2023-08-10 | $25.87M derived: sum of 4 quarters · filed 2023-08-10 | ||||||
| 2022-03-31 | $7.07M 10-Q · filed 2023-05-10 | $12.28M derived: sum of 2 quarters · filed 2023-05-10 | $18.44M derived: sum of 3 quarters · filed 2023-05-10 | $23.95M derived: sum of 4 quarters · filed 2023-05-10 | ||||||
| 2021-12-31 | $5.21M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $11.36M derived: sum of 2 quarters · filed 2023-03-22 | $16.88M derived: sum of 3 quarters · filed 2023-03-22 | $22.97M 10-K · filed 2023-03-22 | ||||||
| 2021-09-30 | $6.16M 10-Q · filed 2022-11-10 | $11.67M derived: sum of 2 quarters · filed 2022-11-10 | $17.76M 10-Q · filed 2022-11-10 | $21.26M derived: sum of 4 quarters · filed 2022-11-10 | ||||||
| 2021-06-30 | $5.52M 10-Q · filed 2022-08-12 | $11.61M 10-Q · filed 2022-08-12 | $15.10M derived: sum of 3 quarters · filed 2022-08-12 | $21.25M derived: sum of 4 quarters · filed 2022-08-12 | ||||||
| 2021-03-31 | $6.09M 10-Q · filed 2022-05-11 | $9.58M derived: sum of 2 quarters · filed 2022-05-11 | $15.73M derived: sum of 3 quarters · filed 2022-05-11 | $20.77M derived: sum of 4 quarters · filed 2022-05-11 | ||||||
| 2020-12-31 | $3.50M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $9.65M derived: sum of 2 quarters · filed 2022-03-24 | $14.68M derived: sum of 3 quarters · filed 2022-03-24 | $19.74M 10-K · filed 2022-03-24 | ||||||
| 2020-09-30 | $6.15M 10-Q · filed 2021-11-10 | $11.19M derived: sum of 2 quarters · filed 2021-11-10 | $16.25M 10-Q · filed 2021-11-10 | $21.06M derived: sum of 4 quarters · filed 2021-11-10 | ||||||
| 2020-06-30 | $5.03M 10-Q · filed 2021-08-11 | $10.10M 10-Q · filed 2021-08-11 | $14.91M derived: sum of 3 quarters · filed 2021-08-11 | $19.42M derived: sum of 4 quarters · filed 2021-08-11 | ||||||
| 2020-03-31 | $5.06M 10-Q · filed 2021-05-12 | $9.88M derived: sum of 2 quarters · filed 2021-05-12 | $14.38M derived: sum of 3 quarters · filed 2021-05-12 | $18.02M derived: sum of 4 quarters · filed 2021-05-12 | ||||||
| 2019-12-31 | $4.81M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-24 | $9.32M derived: sum of 2 quarters · filed 2021-03-24 | $12.95M derived: sum of 3 quarters · filed 2021-03-24 | $17.52M 10-K · filed 2021-03-24 | ||||||
| 2019-09-30 | $4.51M 10-Q · filed 2020-11-12 | $8.14M derived: sum of 2 quarters · filed 2020-11-12 | $12.71M 10-Q · filed 2020-11-12 | $17.05M derived: sum of 4 quarters · filed 2020-11-12 | ||||||
| 2019-06-30 | $3.63M 10-Q · filed 2020-08-12 | $8.20M 10-Q · filed 2020-08-12 | $12.54M derived: sum of 3 quarters · filed 2020-08-12 | $15.13M derived: sum of 4 quarters · filed 2020-08-12 | ||||||
| 2019-03-31 | $4.57M 10-Q · filed 2020-05-11 | $8.91M derived: sum of 2 quarters · filed 2020-05-11 | $11.50M derived: sum of 3 quarters · filed 2020-05-11 | $16.96M derived: sum of 4 quarters · filed 2020-05-11 | ||||||
| 2018-12-31 | $4.34M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-19 | $6.93M derived: sum of 2 quarters · filed 2020-03-19 | $12.39M derived: sum of 3 quarters · filed 2020-03-19 | $15.03M 10-K · filed 2020-03-19 | ||||||
| 2018-09-30 | $2.59M 10-Q · filed 2019-11-12 | $8.05M derived: sum of 2 quarters · filed 2019-11-12 | $10.69M 10-Q · filed 2019-11-12 | $14.08M derived: sum of 4 quarters · filed 2019-11-12 | ||||||
| 2018-06-30 | $5.46M 10-Q · filed 2019-08-16 | $8.10M 10-Q · filed 2019-08-16 | $11.49M derived: sum of 3 quarters · filed 2019-08-16 | $13.89M derived: sum of 4 quarters · filed 2019-08-16 | ||||||
| 2018-03-31 | $2.64M 10-Q · filed 2019-05-13 | $6.03M derived: sum of 2 quarters · filed 2019-05-13 | $8.43M derived: sum of 3 quarters · filed 2019-05-13 | $9.75M derived: sum of 4 quarters · filed 2019-05-13 | ||||||
| 2017-12-31 | $3.39M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-21 | $5.80M derived: sum of 2 quarters · filed 2019-02-21 | $7.12M derived: sum of 3 quarters · filed 2019-02-21 | $8.65M 10-K · filed 2019-02-21 | ||||||
| 2017-09-30 | $2.40M 10-Q · filed 2018-11-13 | $3.72M derived: sum of 2 quarters · filed 2018-11-13 | $5.26M 10-Q · filed 2018-11-13 | $6.68M derived: sum of 4 quarters · filed 2018-11-13 | ||||||
| 2017-06-30 | $1.32M 10-Q · filed 2018-08-10 | $2.86M 10-Q · filed 2018-08-10 | $4.27M derived: sum of 3 quarters · filed 2018-08-10 | $5.69M derived: sum of 4 quarters · filed 2018-08-10 | ||||||
| 2017-03-31 | $1.53M 10-Q · filed 2018-05-14 | $2.95M derived: sum of 2 quarters · filed 2018-05-14 | $4.37M derived: sum of 3 quarters · filed 2018-05-14 | $5.10M derived: sum of 4 quarters · filed 2018-05-14 | ||||||
| 2016-12-31 | $1.42M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-28 | $2.84M derived: sum of 2 quarters · filed 2018-03-28 | $3.56M derived: sum of 3 quarters · filed 2018-03-28 | $3.88M 10-K · filed 2018-03-28 | $3.88M 10-K · filed 2017-04-03 | |||||
| 2016-09-30 | $1.42M 10-Q · filed 2017-11-13 | $1.42M 10-Q · filed 2016-11-21 | $2.15M derived: sum of 2 quarters · filed 2017-11-13 | $2.47M 10-Q · filed 2017-11-13 | $2.47M 10-Q · filed 2016-11-21 | |||||
| 2016-06-30 | $724.00K 10-Q · filed 2017-08-11 | $980.38K 10-Q · filed 2016-08-15 | $1.04M 10-Q · filed 2017-08-11 | $1.30M 10-Q · filed 2016-08-15 | ||||||
| 2016-03-31 | $321.00K 10-Q · filed 2017-05-12 | $320.57K 10-Q · filed 2016-06-16 | ||||||||
| 2015-12-31 | $738.23K 10-K · filed 2017-04-03 | |||||||||
| 2015-09-30 | $222.75K 10-Q · filed 2016-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |